(3-R)-1,3-dihydro-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one,
L 364373,
L-364,373,
L364373,
R-L3,
L-364,373,
103342-82-1,
AC1LCVIT,
CCK antagonist synthetic 11,
CHEBI:34942,
C13824,
(3R)-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-3H-1,4-benzodiazepin-2-one,
R-L364,373,
SureCN7515330,
GTPL2595,
SCHEMBL7515330,
CHEMBL1907717,
BDBM82388,
CTK8F0250,
DTXSID90349652,
ZINC4654954,
AKOS024457225,
NCGC00378686-01,
RT-013477,
B7142,
J-000943,
5-(2-FLUOROPHENYL)-1,3-DIHYDRO-3-(1H-INDOL-3-YLMETHYL)-1-METHYL-2H-1,4-BENZODIAZEPIN-2-ONE,
D05GQK,
CGBANSGENFERAT-JOCHJYFZSA-N,
CID656755,
C113498,
L364373,
L 364373,
(3-R)-1,3-dihydro-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one,